Surgery – Truss – Pad
Patent
1989-11-21
1991-11-19
Rosenbaum, C. Fred
Surgery
Truss
Pad
128632, 424 9, 604 49, A61B 500
Patent
active
050657470
ABSTRACT:
Somatostatin, a growth hormone suppressant, is administered to an individual before the growth hormone secretion of that individual is provoked. The somatostatin is applied first in bolus form and the bolus administration is followed by a prolonged adminstration of the somatostatin. Both the bolus and the subsequent adminstration of growth hormone suppressant can be administered intravenously. This procedure insures that the growth hormone secretion of the individual's pituitary gland will be reduced to a minimum, thereby insuring that the results of subsequent provocative tests will be standardized and thus interpreted more consistently.
REFERENCES:
patent: 4230617 (1980-10-01), Sarantakis
patent: 4261885 (1981-04-01), Sakakibara et al.
patent: 4410512 (1983-10-01), Bowers
patent: 4727041 (1988-02-01), Aroonsakal
patent: 4747825 (1986-05-01), Linkie et al.
patent: 4844096 (1989-07-01), Berco
Mason, Jr. Joseph C.
Polutta Mark O.
Rosenbaum C. Fred
Smith Ronald E.
University of South Florida
LandOfFree
Method for improving the accuracy of diagnosis of growth hormone does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for improving the accuracy of diagnosis of growth hormone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for improving the accuracy of diagnosis of growth hormone will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1363142